Riskpilot← Back to searchSign inGet full accessApotek i Landala AB
ABActiveOrg 5568029119Economic activity was not specified by tax authority · NACE 0000Est. 20100 employees
Revenue 2025
SEK 0
EBITDA margin
—
+13% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
SEK 690K
-20% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | +13% |
| Net profit | SEK 690K | -20% |
| Total assets | SEK 33,4M | +1% |
| Equity | SEK 33,2M | +1% |
| Employees | 0 | — |
Legal name
Apotek i Landala AB
Org number
5568029119
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
29 mars 2010
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till förmål för sin verksamhet att förvalta aktier i bolag som bedriver apoteksverksamhet samt att, direkt eller indirekt, äga och förvalta övrig fast och lös egendom och därmed förenlig verksamhet.
Address
Email
nahidbahramian57@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −9 | −7 | −10 | −11 | −9 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −9 | −7 | −10 | −11 | −9 |
| Net financials | 319 | 402 | 637 | 1 096 | 879 |
| Profit before tax | 311 | 395 | 627 | 1 086 | 870 |
| Tax | −64 | −81 | −129 | −223 | −180 |
| Net profit | 247 | 314 | 498 | 862 | 690 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 31 798 | 31 934 | 32 219 | 33 101 | 33 410 |
| Equity | 31 667 | 31 781 | 32 083 | 32 741 | 33 222 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 131 | 152 | 136 | 360 | 188 |
| Total debt | 131 | 152 | 136 | 360 | 188 |
EBITDA margin
-939300.0%
This company
15.8%
Market median
-5945037% vs market
20212025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
68987500.0%
This company
8.1%
Market median
+851697431% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apotek i Landala AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annahita Nikavar | Deputy Board Member | 0 companies |
| Nahid Bahramian Babakhany | Board of Directors | 0 companies |